High tide closes acquisition of a majority stake in remexian pharma gmbh

Calgary, ab , sept. 2, 2025 /prnewswire/ - high tide inc. ("high tide" or the "company") (nasdaq: hiti) (tsxv: hiti) (fse: 2lya), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to announce, that further to its press release dated august 14, 2025 (the "august 14 release"), the company has completed the acquisition of a 51% interest in remexian for an estimated purchase price of €26.4 million, such amount to be finalized in 30 days, once the final closing balance sheet is available, and will have a five-year option to acquire the remaining 49% of remexian at any time after 24 months.
HITI Ratings Summary
HITI Quant Ranking